Arkadios Wealth Advisors trimmed its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 6.1% in the 4th quarter, ...

Danaher Corp (DHR) stock saw a decline, ending the day at $238.36 which represents a decrease of $-3.54 or -1.46% from the prior close of $241.9. The stock opened at $242.17 and touched a low of $238.

Assenagon Asset Management S.A. trimmed its stake in Danaher Co. (NYSE:DHR – Free Report) by 2.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange ...

Danaher executed a $4.5 billion share buyback, with an additional 20 million shares authorized. Learn why I remain bullish on ...

Washington, DC-based Danaher Corporation (DHR) is a leading global life sciences and diagnostics innovator, helping solve ...

Shares of Danaher Corp. DHR advanced 1.65% to $241.90 Thursday, on what proved to be an all-around dismal trading session for ...

Danaher Corp. closed $44.08 short of its 52-week high ($281.70), which the company achieved on August 1st.

Buying $100 In DHR: If an investor had bought $100 of DHR stock 10 years ago, it would be worth $431.90 today based on a ...

Goldman Sachs analyst Matthew Sykes lowered the firm’s price target on Danaher (DHR) to $250 from $255 and keeps a Neutral rating on the shares ...

DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow ...

In a report released today, Luke Sergott from Barclays maintained a Hold rating on Danaher (DHR – Research Report), with a price target of ...

Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company's fourth quarter 2024 performance in a ...